XTX Topco’s Sunshine Biopharma SBFM Stock Holding History

XTX Topco’s Portfolio SBFM Stock Details SBFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,146	Closed	-$22.3K	–	4641
2026 Q1	$22.3K	Buy	2,146 +530	+33%	+$6.25K	﹤0.01%	3522
2025 Q4	$19.9K	Buy	+1,616	New	+$25.5K	﹤0.01%	3060
2024 Q3	–	Sell	-220	Closed	-$18.4K	–	2539
2024 Q2	$18.4K	Buy	220 +217	+7,233%	+$103K	﹤0.01%	1624
2024 Q1	$3.25K	Buy	3 +2	+200%	+$5.88K	﹤0.01%	1745
2023 Q4	$4.75K	Buy	+1	New	+$5.69K	﹤0.01%	1478

Other funds holding SBFM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

CIAM

Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

SFG

Strive Financial Group Carmel, Indiana $230M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

XTX Topco's SBFM Position: Q2 2026 in Review

XTX Topco sold out of Sunshine Biopharma (SBFM) in Q2 2026, closing a stake of 2,146 shares — an estimated $22.3K sold.

XTX Topco first reported a position in SBFM in Q4 2023 and held it in 5 quarters. The position peaked at $22.3K in Q1 2026. 9 funds tracked by Wall St. Rank hold SBFM as of Q2 2026.

XTX Topco reported no remaining Sunshine Biopharma position as of Q2 2026 after selling out during the quarter.
XTX Topco sold 2,146 Sunshine Biopharma shares in Q2 2026, an estimated $22.3K.
XTX Topco first reported a position in Sunshine Biopharma in Q4 2023 and held it in 5 quarters.
XTX Topco's Sunshine Biopharma position peaked at $22.3K in Q1 2026.
9 funds tracked by Wall St. Rank held Sunshine Biopharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.